Emulsion concentrate containing water-soluble and oil-soluble polymers
    4.
    发明申请
    Emulsion concentrate containing water-soluble and oil-soluble polymers 审中-公开
    含有水溶性和油溶性聚合物的乳液浓缩物

    公开(公告)号:US20050276763A1

    公开(公告)日:2005-12-15

    申请号:US11132821

    申请日:2005-05-19

    摘要: The present invention is the preparation and use of an emulsion concentrate obtainable by drying an oil-in-water emulsion comprising a lipid phase, one or more oil-soluble polymers; an aqueous phase, one or more water-soluble polymers, one or more UV photoprotective filters and optionally further cosmetic or dermatological active ingredients, auxiliaries and additives, to produce a water content of from 0.1 to 20% by weight, based on the total weight of the dried preparation.

    摘要翻译: 本发明是通过干燥包含脂质相,一种或多种油溶性聚合物的水包油乳液得到的乳液浓缩物的制备和用途; 水相,一种或多种水溶性聚合物,一种或多种UV光保护过滤器和任选的其它化妆品或皮肤病学活性成分,助剂和添加剂,以基于总重量产生0.1至20重量%的水含量 的干燥制剂。

    EMULSIFIER-FREE, POLYMER-STABILIZED FOAM FORMULATIONS
    9.
    发明申请
    EMULSIFIER-FREE, POLYMER-STABILIZED FOAM FORMULATIONS 有权
    无乳化剂,聚合物稳定的泡沫配方

    公开(公告)号:US20120244093A1

    公开(公告)日:2012-09-27

    申请号:US13514687

    申请日:2010-12-10

    申请人: Rolf Daniels

    发明人: Rolf Daniels

    摘要: The invention relates to a foam formulation comprising a substantially emulsifier-free emulsion of the oil-in-water type, comprising an oil phase and an aqueous phase, the emulsion comprising at least one surface active, ionic polymer with a molecular weight of more than 5000 g/mol, wherein the ionic polymer is a copolymer comprising as monomer units an ionic monomer (M1) and at least one further monomer.

    摘要翻译: 本发明涉及一种泡沫制剂,其包含基本上不含乳化剂的水包油型乳液,其包含油相和水相,所述乳液包含至少一种分子量大于或等于1的表面活性离子聚合物 5000g / mol,其中离子聚合物是包含作为单体单元的离子单体(M1)和至少一种其它单体的共聚物。

    Radiotherapeutic formulations containing 224RA and a method for their production
    10.
    发明授权
    Radiotherapeutic formulations containing 224RA and a method for their production 有权
    含224RA的放射治疗剂及其制备方法

    公开(公告)号:US07887782B2

    公开(公告)日:2011-02-15

    申请号:US10362049

    申请日:2001-08-07

    IPC分类号: A61K51/00 A61M36/14

    CPC分类号: A61K51/02 A61K51/121

    摘要: The invention relates to novel radiotherapeutic formulations containing 224Ra and methods for their production. The invention discloses, in particular, radiotherapeutic formulations comprising at least one salt of the isotope 224Ra, which are characterized in that the content of other radionuclides, in particular, the respective content of certain longeval radionuclides does not exceed a specific numerical value in mBq/g. The invention also relates to a method for producing radiotherapeutic formulations of this type, which is characterized by the following steps: after at least one centrifugation of an aqueous suspension of the compound 228Th(OH)4 and optionally after the resuspension of the raw sediment obtained in said centrifugation, the precipitated 228Th(OH)4 sediment is separated. The supernatant solution of a 224Ra salt that has been obtained is subsequently subjected to sterile filtration and is then made up to the required dose. Finally, said solution is sterilized and bottled in ampoules in a manner known per se.

    摘要翻译: 本发明涉及含有224Ra的新型放射治疗剂及其制备方法。 本发明特别公开了包含至少一种同位素224Ra盐的放射治疗制剂,其特征在于其它放射性核素的含量,特别是某些长寿放射性核素的含量不超过特定的数值,以mBq / G。 本发明还涉及这种类型的放射治疗剂的制备方法,其特征在于以下步骤:在化合物228Th(OH)4的水性悬浮液至少一次离心后,任选地在所得到的沉淀物再悬浮后 在离心过程中,析出的沉淀物228Th(OH)4分离。 随后将已经获得的224Ra盐的上清液进行无菌过滤,然后使其达到所需剂量。 最后,所述溶液以本身已知的方式灭菌并装入安瓿瓶中。